Comparison of midazolam and low-dose dexmedetomidine in flexible bronchoscopy: A prospective, randomized, double-blinded study
- PMID: 32201443
- PMCID: PMC7074428
- DOI: 10.4103/ijp.IJP_287_19
Comparison of midazolam and low-dose dexmedetomidine in flexible bronchoscopy: A prospective, randomized, double-blinded study
Abstract
Background: Dexmedetomidine is a clinically useful drug for providing sedation, but concern regarding its cardiovascular side effect profile can limit its widespread use during routine diagnostic flexible bronchoscopy (FB).
Materials and methods: Patients between 18 and 65 years of age, who required diagnostic FB, were screened. Eligible patients were randomized to either receive 0.5 μg/kg intravenous dexmedetomidine over 10 min or intravenous midazolam 0.035 mg/kg over 1 min. If required, rescue medication (intravenous midazolam 0.5 mg bolus) was administered. The primary outcome measure was the composite score. Other parameters observed were numerical rating scale, hemodynamic variables, oxygen saturation, number of doses of rescue medication, visual analog scale score for cough, ease of bronchoscopy, Ramsay Sedation Score, and postprocedure patient response after 24 h of bronchoscopy.
Results: A total of 54 patients were enrolled, 27 in each group. Total composite score (mean ± standard deviation) in dexmedetomidine and midazolam group at nasopharynx was 7.04 ± 2.19 and 6.59 ± 1.55 (P = 0.387), respectively. The corresponding values at the level of trachea were 9.22 ± 3.69 and 8.63 ± 2.13 (P = 0.475). In the dexmedetomidine group, patient response after 24 h of bronchoscopy showed the quality of sedation to be excellent in three patients, good in 10, fair in 11, and poor in 3 and discomfort to be nil in 14, mild 7, moderate in 3, and severe in 3. The corresponding values in the midazolam group for the quality of sedation were 0, 9, 18, 0 and for discomfort 10, 16, 1, 0. Other parameters did not reveal any statistically significant difference.
Conclusion: Dexmedetomidine at a dose of 0.5 μg/kg may provide clinically useful conscious sedation, comparable to midazolam.
Keywords: Dexmedetomidine; flexible bronchoscopy; midazolam; sedation.
Copyright: © 2020 Indian Journal of Pharmacology.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Clinical usefulness of intermediate-dose dexmedetomidine (0.75 μg/kg) in flexible bronchoscopy - A prospective, randomized, double-blinded study.Indian J Pharmacol. 2021 Nov-Dec;53(6):440-447. doi: 10.4103/ijp.IJP_446_20. Indian J Pharmacol. 2021. PMID: 34975131 Free PMC article. Clinical Trial.
-
Comparison Between Dexmedetomidine and Midazolam-Fentanyl Combination in Flexible Bronchoscopy: A Prospective, Randomized, Double-blinded Study.J Bronchology Interv Pulmonol. 2024 Aug 29;31(4):e0985. doi: 10.1097/LBR.0000000000000985. eCollection 2024 Oct 1. J Bronchology Interv Pulmonol. 2024. PMID: 39207016 Clinical Trial.
-
Intravenous Dexmedetomidine Provides Superior Patient Comfort and Tolerance Compared to Intravenous Midazolam in Patients Undergoing Flexible Bronchoscopy.Pulm Med. 2015;2015:727530. doi: 10.1155/2015/727530. Epub 2015 Oct 12. Pulm Med. 2015. PMID: 26543645 Free PMC article. Clinical Trial.
-
Comparison of dexmedetomidine with midazolam for third molar surgery: A meta-analysis of randomized controlled trials.Medicine (Baltimore). 2023 Jun 23;102(25):e33155. doi: 10.1097/MD.0000000000033155. Medicine (Baltimore). 2023. PMID: 37352026 Free PMC article.
-
Comparison of dexmedetomidine with midazolam for dental surgery: A systematic review and meta-analysis.Medicine (Baltimore). 2020 Oct 23;99(43):e22288. doi: 10.1097/MD.0000000000022288. Medicine (Baltimore). 2020. PMID: 33120732 Free PMC article.
Cited by
-
Effects of dexmedetomidine in non-operating room anesthesia in adults: a systematic review with meta-analysis.Braz J Anesthesiol. 2023 Sep-Oct;73(5):641-664. doi: 10.1016/j.bjane.2021.12.002. Epub 2021 Dec 20. Braz J Anesthesiol. 2023. PMID: 34933035 Free PMC article. Review.
-
Use of high-flow nasal cannula and intravenous propofol sedation while performing flexible video bronchoscopy in the intensive care unit: Case reports.SAGE Open Med Case Rep. 2021 Dec 8;9:2050313X211061911. doi: 10.1177/2050313X211061911. eCollection 2021. SAGE Open Med Case Rep. 2021. PMID: 34900258 Free PMC article.
-
Effect of different doses of midazolam combined with fentanyl during painless bronchoscopy in adults.Am J Transl Res. 2023 Jan 15;15(1):563-572. eCollection 2023. Am J Transl Res. 2023. PMID: 36777843 Free PMC article.
-
Effectiveness of nebulized dexmedetomidine as a premedication in flexible bronchoscopy in Indian patients -a prospective, randomized, double-blinded study.Contemp Clin Trials Commun. 2023 Mar 13;33:101111. doi: 10.1016/j.conctc.2023.101111. eCollection 2023 Jun. Contemp Clin Trials Commun. 2023. PMID: 36969987 Free PMC article. No abstract available.
-
Clinical usefulness of intermediate-dose dexmedetomidine (0.75 μg/kg) in flexible bronchoscopy - A prospective, randomized, double-blinded study.Indian J Pharmacol. 2021 Nov-Dec;53(6):440-447. doi: 10.4103/ijp.IJP_446_20. Indian J Pharmacol. 2021. PMID: 34975131 Free PMC article. Clinical Trial.
References
-
- Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: Accredited by NICE. Thorax. 2013;68(Suppl 1):i1–44. - PubMed
-
- Barnett AM, Jones R, Simpson G. A survey of bronchoscopy practice in Australia and New Zealand. J Bronchology Interv Pulmonol. 2016;23:22–8. - PubMed
-
- Hwang J, Jeon Y, Park HP, Lim YJ, Oh YS. Comparison of alfetanil and ketamine in combination with propofol for patient-controlled sedation during fiberoptic bronchoscopy. Acta Anaesthesiol Scand. 2005;49:1334–8. - PubMed